Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. - Wikidata - awgldk - TriplyDB

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.

http://www.wikidata.org/entity/Q30275382

about

Impact of lenalidomide-based induction therapy on the mobilization of CD34(+) cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.

P2860

Q38691698-DA32F7A0-BD05-40A0-8862-5ADA6C6683D2

P2860

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.

http://www.wikidata.org/entity/Q30275382

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Maintenance versus Induction T ...... antation for Multiple Myeloma.

@ast

Maintenance versus Induction T ...... antation for Multiple Myeloma.

@en

type

label

Maintenance versus Induction T ...... antation for Multiple Myeloma.

@ast

Maintenance versus Induction T ...... antation for Multiple Myeloma.

@en

prefLabel

Maintenance versus Induction T ...... antation for Multiple Myeloma.

@ast

Maintenance versus Induction T ...... antation for Multiple Myeloma.

@en

P1433

Q30275382-E4F96EBA-1E33-4062-A2AC-3AF96FB3A351

P1476

Q30275382-2A3D852F-F1F5-472F-9335-FBC912C516F4

P2093

Q30275382-0F291EBC-4768-451E-8E94-33649F2F7D78

Q30275382-167C731E-D0E7-4FA2-BDF5-3ABC34A8AC08

Q30275382-16BD0092-A174-4664-945D-3EF07C3F94BD

Q30275382-174C8E98-A3FB-471E-93D5-50D726DA30E4

Q30275382-18D301A0-D8DA-45F0-A2F1-1F2D55B6EA23

Q30275382-1969D914-BAAD-435C-A09B-F93BC6F25489

Q30275382-27DC2803-6EB1-4CE8-9B03-29E7169FD92A

Q30275382-3368E65E-E3B6-4291-B827-C4400621EA16

Q30275382-419F66DD-5B63-419C-BA2B-36C51F6FFC7A

Q30275382-4213882E-AAFE-42E4-840D-3905C6307285

P2860

Q30275382-0AED1D41-01B4-4F56-A68D-B69F7DF0C5DA

Q30275382-1694017D-5EF5-4C1F-AAF2-D6AD24A425D2

Q30275382-2FBB363D-D46D-4B32-9775-E54C71D113E6

Q30275382-3AE34D0A-CA16-45A4-9927-AB3B89D26CF2

Q30275382-5BC3E939-ACE1-4DCF-8B26-121B42F1A4CB

Q30275382-5E423763-A051-4CDB-80B7-AFF58CCBB2EB

Q30275382-63BC354F-2D0E-41C3-87E8-FD6719040D5F

Q30275382-6DB2A092-9417-4DEC-95A8-7EFE9AC1F745

Q30275382-71E989C2-A097-4F0A-8765-1ACCEBD2FDF2

Q30275382-757395FD-71FB-4011-B111-D6632694EBAA

P304

Q30275382-377F2C12-FCDF-4C94-8E34-72B6E0953CE4

P31

Q30275382-868708A0-31F2-48FB-A6AE-59B9EF425A25

P356

Q30275382-200A0788-1DF3-43A2-AD45-1B334942C66A

P433

Q30275382-98680A7D-E8E6-40EC-8B55-C0C4285982ED

P478

Q30275382-5F8D9D1C-2F59-486E-B6DE-8740A8232087

P50

Q30275382-5D359BD1-1BF0-4383-A1BD-B9AE95EC19EB

Q30275382-98D43A5F-8052-4381-81CB-C37FD17FE41F

Q30275382-B8095E25-F0E5-4669-8D28-77BC6EFA0914

Q30275382-CA50F239-D0DD-49CD-9562-DA7B46336CD2

Q30275382-E55EF54D-809B-4F1C-81BC-DA29789B7F76

Q30275382-E71B59E0-19AF-4309-9CE9-E217B32D39BF

Q30275382-F5E269E6-AA34-437C-9648-FD994C9DFC3A

P577

Q30275382-8CD6AF92-4938-4F91-8596-5C8FF5216310

P698

Q30275382-EA1A3035-2701-405C-9E5A-14B8C1F823AD

P932

Q30275382-92A8739D-802A-4C64-B0BB-38D5CA068603

P356

J.BBMT.2016.11.011

P1433

Biology of Blood and Marrow Transplantation

P1476

Maintenance versus Induction T ...... antation for Multiple Myeloma.

@en

P2093

Adetola A Kassim

http://www.w3.org/2001/XMLSchema#string

Amrita Krishnan

http://www.w3.org/2001/XMLSchema#string

Angelo Maiolino

http://www.w3.org/2001/XMLSchema#string

Anita D'Souza

http://www.w3.org/2001/XMLSchema#string

Asad Bashey

http://www.w3.org/2001/XMLSchema#string

Baldeep M Wirk

http://www.w3.org/2001/XMLSchema#string

Cindy Lee

http://www.w3.org/2001/XMLSchema#string

César Freytes

http://www.w3.org/2001/XMLSchema#string

Dan Vogl

http://www.w3.org/2001/XMLSchema#string

David I Marks

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data.

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial.

Lenalidomide after stem-cell transplantation for multiple myeloma

Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma.

Multiple myeloma.

Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

Molecular pathogenesis and a consequent classification of multiple myeloma.

P304

269-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2016.11.011

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Robert Peter Gale

Parameswaran Hari

Miguel Angel Diaz

Hillard M Lazarus

P577

2016-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27864161

http://www.w3.org/2001/XMLSchema#string

P932

5346183

http://www.w3.org/2001/XMLSchema#string